Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,311 | 735 | 99.9% |
| Education | $15.28 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $900.06 | 45 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $867.84 | 68 | $0 (2023) |
| ABBVIE INC. | $774.83 | 78 | $0 (2024) |
| Lilly USA, LLC | $660.26 | 52 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $659.04 | 54 | $0 (2023) |
| Novo Nordisk Inc | $618.91 | 45 | $0 (2023) |
| GlaxoSmithKline, LLC. | $595.52 | 57 | $0 (2024) |
| Astellas Pharma US Inc | $467.05 | 30 | $0 (2023) |
| Merck Sharp & Dohme LLC | $461.75 | 40 | $0 (2023) |
| Amarin Pharma Inc. | $461.50 | 26 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $35.18 | 2 | ABBVIE INC. ($18.09) |
| 2023 | $1,878 | 123 | AbbVie Inc. ($306.92) |
| 2022 | $1,448 | 110 | ABBVIE INC. ($210.54) |
| 2021 | $1,117 | 92 | AbbVie Inc. ($220.75) |
| 2020 | $829.51 | 53 | Janssen Pharmaceuticals, Inc ($209.74) |
| 2019 | $1,525 | 114 | Janssen Pharmaceuticals, Inc ($254.76) |
| 2018 | $1,869 | 118 | AstraZeneca Pharmaceuticals LP ($230.91) |
| 2017 | $1,624 | 125 | SANOFI-AVENTIS U.S. LLC ($220.41) |
All Payment Transactions
737 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: NEUROSCIENCE | ||||||
| 02/19/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: VACCINES | ||||||
| 12/21/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: Diabetes | ||||||
| 12/18/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Cardio-renal | ||||||
| 12/14/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: Biological | ||||||
| 12/14/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $4.44 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Gastroenterology | ||||||
| 12/05/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/05/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Inflammation | ||||||
| 12/01/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: PAIN | ||||||
| 11/28/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Diabetes | ||||||
| 11/20/2023 | Merck Sharp & Dohme LLC | VAXELIS (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: VACCINE | ||||||
| 11/17/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $3.85 | General |
| Category: Diabetes | ||||||
| 11/16/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Endocrinology | ||||||
| 11/15/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Diabetes | ||||||
| 11/15/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: Diabetes | ||||||
| 11/14/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/13/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.07 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/01/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus, Tresiba | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: Diabetes | ||||||
| 10/31/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.08 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/12/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Spinal Cord Neurostimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 473 | 757 | $128,393 | $59,971 |
| 2022 | 5 | 555 | 907 | $150,345 | $71,501 |
| 2021 | 9 | 663 | 1,023 | $156,238 | $57,264 |
| 2020 | 12 | 787 | 1,125 | $168,895 | $69,683 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 176 | 391 | $75,463 | $32,041 | 42.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 153 | 153 | $31,824 | $19,174 | 60.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 145 | $18,850 | $7,708 | 40.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 14 | 15 | $1,620 | $602.85 | 37.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 33 | 53 | $636.00 | $445.20 | 70.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 184 | 415 | $80,095 | $34,995 | 43.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 165 | 165 | $34,320 | $21,149 | 61.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 146 | 236 | $30,680 | $12,826 | 41.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 14 | 14 | $4,326 | $2,303 | 53.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 46 | 77 | $924.00 | $228.69 | 24.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 203 | 408 | $78,744 | $22,082 | 28.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 137 | 137 | $28,496 | $17,899 | 62.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 153 | 257 | $33,410 | $9,554 | 28.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 26 | 26 | $8,034 | $4,313 | 53.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 19 | 20 | $3,200 | $1,527 | 47.7% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 18 | 18 | $1,908 | $1,166 | 61.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 67 | 107 | $1,284 | $321.00 | 25.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 18 | 18 | $810.00 | $291.18 | 35.9% |
| 81002 | Urinalysis, manual test | Office | 2021 | 22 | 32 | $352.00 | $111.36 | 31.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 185 | 340 | $65,620 | $23,293 | 35.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 97 | 97 | $20,176 | $11,066 | 54.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 153 | 242 | $31,460 | $9,905 | 31.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 81 | 122 | $19,100 | $9,482 | 49.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 48 | 48 | $14,832 | $8,050 | 54.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 26 | 29 | $7,569 | $3,224 | 42.6% |
About Dr. Chad Dunkle, M.D
Dr. Chad Dunkle, M.D is a Family Medicine healthcare provider based in Hamilton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1275532590.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chad Dunkle, M.D has received a total of $10,326 in payments from pharmaceutical and medical device companies, with $35.18 received in 2024. These payments were reported across 737 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($10,311).
As a Medicare-enrolled provider, Dunkle has provided services to 2,478 Medicare beneficiaries, totaling 3,812 services with total Medicare billing of $258,419. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Hamilton, OH
- Active Since 07/19/2005
- Last Updated 01/07/2015
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1275532590
Products in Payments
- FARXIGA (Drug) $699.48
- XARELTO (Drug) $678.52
- JARDIANCE (Drug) $580.09
- Vascepa (Drug) $461.50
- UBRELVY (Drug) $317.93
- Ozempic (Drug) $291.39
- Otezla (Drug) $272.91
- Livalo (Drug) $247.12
- Kerendia (Drug) $236.23
- ENTRESTO (Drug) $231.96
- TOUJEO (Drug) $217.28
- VRAYLAR (Drug) $205.68
- JANUVIA (Drug) $200.21
- TRULICITY (Drug) $198.35
- QULIPTA (Drug) $196.44
- Aimovig (Biological) $195.65
- TRELEGY ELLIPTA (Drug) $194.99
- INVOKANA (Drug) $189.32
- SYMBICORT (Drug) $188.34
- MYRBETRIQ (Drug) $181.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hamilton
Dr. Rajesh Khanna, M.d, M.D
Family Medicine — Payments: $19,569
Dr. Mini Pathrose, M.d, M.D
Family Medicine — Payments: $13,647
Dr. Thomas Willke, M.d, M.D
Family Medicine — Payments: $10,650
Harvard Heath, M.d, M.D
Family Medicine — Payments: $7,970
William Fenton, Md, MD
Family Medicine — Payments: $7,104
Kathleen Harder-Brouwer, Md, MD
Family Medicine — Payments: $5,625